Toward a future where cardiac electrophysiology is understood more deeply.
The heart beats in response to electrical signals, and much about how that electrical activity behaves is still not fully understood. We believe that deepening this understanding, step by step, can open up new options for the care of people with arrhythmias.
Turning clinical questions into research and development, through engineering.
Starting from the questions that arise in arrhythmia care, we bring together expertise in medicine, engineering, and business development to research and develop software for cardiac electrophysiology.
What we do
Catheter ablation for atrial fibrillation is one of the most widely performed procedures in cardiac electrophysiology, and outcomes still vary between patients and between operators.
OpMap was founded by physicians and engineers who work in this field. We are developing software that processes intracardiac signals recorded during electrophysiology procedures. The work is in research and development, and we are building it together with clinicians rather than for them.
Our software is at the research and development stage. It is not approved or cleared for clinical use in any jurisdiction, in Japan or overseas. Nothing on this site is intended as advertising for a medical device.
Partnership
Who we would like to meetCompany
Company- Name
- OpMap Inc. (OpMap株式会社)
- Founded
- April 2026
- Location
- Bunkyo-ku, Tokyo, Japan
- Representative
- Akihiro Komasa, Representative Director
- Directors
- Naoki Tomii, Director & CSO / Hiroshi Seno, Director & CEO
- Business
- Research and development of software for cardiac electrophysiology
Contact
For partnerships, research collaboration, investment, or joining the team, please get in touch.